{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:34:35Z","timestamp":1793140475260,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.xphs.2026.104534","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:26:01Z","timestamp":1791386761000},"page":"104534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CAGE ionic liquid\u2013mediated co-solubilization of lapatinib and resveratrol enhances cytotoxicity in lung cancer cells with uniform aerosolization for pulmonary delivery"],"prefix":"10.1016","volume":"115","author":[{"given":"Nidhi","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kolimi Prashanth","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudra","family":"Chakravarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8894-9984","authenticated-orcid":false,"given":"Navratan","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipanjan","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7404-4917","authenticated-orcid":false,"given":"Pallab","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.xphs.2026.104534_bib0001","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cllc.2015.01.004","article-title":"Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non e Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker","volume":"16","author":"Ramlau","year":"2015","journal-title":"Clin. Lung Cancer"},{"issue":"6","key":"10.1016\/j.xphs.2026.104534_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajps.2024.100980","article-title":"Biopharmaceutical and pharmacokinetic attributes to drive nanoformulations of small molecule tyrosine kinase inhibitors","volume":"19","author":"Mukherjee","year":"2024","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.xphs.2026.104534_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2024.102693","article-title":"Global burden of lung cancer in 2022 and projections to 2050\u202f: Incidence and mortality estimates from GLOBOCAN","volume":"93","author":"Zhou","year":"2024","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104534_bib0004","first-page":"48","article-title":"Epidermal growth factor receptor (EGFR) in lung cancer\u202f: an overview and update","volume":"2","author":"Bethune","year":"2010","journal-title":"Journal of Thoracic Disease"},{"key":"10.1016\/j.xphs.2026.104534_bib0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/thx.2005.042275","article-title":"Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis","volume":"61","author":"Nakamura","year":"2006","journal-title":"Thora,"},{"issue":"9","key":"10.1016\/j.xphs.2026.104534_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers17091515","article-title":"Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Common Mutations\u202f: New Strategies","volume":"17","author":"Stanzione","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.xphs.2026.104534_bib0007","article-title":"Complex formulation strategies to overcome the delivery hurdles of lapatinib in metastatic breast cancer","volume":"82","author":"Singh","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol"},{"issue":"20","key":"10.1016\/j.xphs.2026.104534_bib0008","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1200\/JCO.2003.11.069","article-title":"Epidermal Growth Factor Receptor in Non \u2013 Small-Cell Lung Carcinomas\u202f: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis","volume":"21","author":"Hirsch","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1016\/j.xphs.2026.104534_bib0009","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1021\/acs.molpharmaceut.5c00684","article-title":"\u201cSupramolecular \u03c0\u2013\u03c0 Interactions Achieve High Loading and Provide pH-Dependent Controlled Release of Lapatinib from Functionalized Graphene Oxide Nanocarriers","volume":"22","author":"Dewangan","year":"2025","journal-title":"Molecular Pharmaceutics"},{"issue":"P2","key":"10.1016\/j.xphs.2026.104534_bib0010","article-title":"Interfacial lipid digestion-responsive injectable nanoemulsions enhance lapatinib efficacy in triple-negative breast cancer","volume":"268","author":"Singh","year":"2026","journal-title":"Colloids Surfaces B Biointerfaces"},{"issue":"1","key":"10.1016\/j.xphs.2026.104534_bib0011","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/B:DRUG.0000047104.45929.ea","article-title":"Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects","volume":"23","author":"Bence","year":"2005","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.xphs.2026.104534_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2026.115062","article-title":"Supersaturated SNEDDS for enhancing the bioavailability of lapatinib ditosylate\u202f: A mechanistic approach to bridge the solubilization-absorption gap","volume":"223","author":"Singh","year":"2026","journal-title":"Eur. J. Pharm. Biopharm"},{"key":"10.1016\/j.xphs.2026.104534_bib0013","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s10637-019-00806-3","article-title":"The influence of the coadministration of the p-glycoprotein modulator elacridar on the pharmacokinetics of lapatinib and its distribution in the brain and cerebrospinal fluid,","volume":"38","author":"Karbownik","year":"2020","journal-title":"Invest New Drugs, vol"},{"issue":"8","key":"10.1016\/j.xphs.2026.104534_bib0014","first-page":"1","article-title":"Exploring resveratrol \u2019 s inhibitory potential on lung cancer stem cells\u202f: a scoping review of mechanistic pathways across cancer models","volume":"42","author":"Raihana","year":"2025","journal-title":"Med. Oncol"},{"key":"10.1016\/j.xphs.2026.104534_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116207","article-title":"Biomedicine & Pharmacotherapy Unveiling the potential effects of resveratrol in lung cancer treatment\u202f: Mechanisms and nanoparticle-based drug delivery strategies","volume":"172","author":"Najafiyan","year":"2024","journal-title":"Biomed. Pharmacother"},{"issue":"2","key":"10.1016\/j.xphs.2026.104534_bib0016","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbamem.2012.10.022","article-title":"Biochimica et Biophysica Acta Nanoencapsulation of quercetin and resveratrol into elastic liposomes","volume":"1828","author":"Cadena","year":"2013","journal-title":"BBA - Biomembr"},{"key":"10.1016\/j.xphs.2026.104534_bib0017","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.2010.05842.x","article-title":"Bioavailability of resveratrol","volume":"1215","author":"Walle","year":"2011","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.xphs.2026.104534_bib0018","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.foodchem.2014.06.082","article-title":"Nutraceutical delivery systems\u202f: Resveratrol encapsulation in grape seed oil nanoemulsions formed by spontaneous emulsification","volume":"167","author":"Davidov-pardo","year":"2015","journal-title":"FOOD Chem"},{"key":"10.1016\/j.xphs.2026.104534_bib0019","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jconrel.2024.10.034","article-title":"Choline geranate ( CAGE ): A multifaceted ionic liquid for drug delivery","volume":"376","author":"Mitragotri","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.xphs.2026.104534_bib0020","doi-asserted-by":"crossref","first-page":"25977","DOI":"10.1039\/D2RA03882J","article-title":"An overview of biomedical applications of choline geranate ( CAGE ): a major breakthrough in drug","volume":"12","author":"Riaz","year":"2022","journal-title":"RSC Adv"},{"issue":"6","key":"10.1016\/j.xphs.2026.104534_bib0021","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1021\/acsbiomaterials.1c00322","article-title":"Ionic Liquid-Enabled Topical Delivery of Immunomodulators","volume":"7","author":"Zhao","year":"2021","journal-title":"ACS Biomaterials Science & Engineering"},{"issue":"28","key":"10.1016\/j.xphs.2026.104534_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.1722338115","article-title":"Ionic liquids for oral insulin delivery","volume":"115","author":"Banerjee","year":"2018","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"10","key":"10.1016\/j.xphs.2026.104534_bib0023","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1007\/s11095-022-03394-9","article-title":"Transdermal Delivery of Metformin Utilizing Ionic Liquid Technology\u202f: Insight Into the Relationship Between Counterion Structures and Properties","volume":"39","author":"Hong","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.xphs.2026.104534_bib0024","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jconrel.2024.09.035","article-title":"Mechanism and performance of choline-based ionic liquids in enhancing nasal delivery of glucagon","volume":"375","author":"Dong","year":"2024","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.xphs.2026.104534_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.125841","article-title":"Ionic liquid-based Ionogel\u202f: A novel strategy to improve dermal delivery and in vivo efficacy of etodolac in rheumatoid arthritis management","volume":"412","author":"Bhamble","year":"2024","journal-title":"J. Mol. Liq"},{"issue":"11","key":"10.1016\/j.xphs.2026.104534_bib0026","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/adhm.201600086","article-title":"Choline and Geranate Deep Eutectic Solvent as a Broad-Spectrum Antiseptic Agent for Preventive and Therapeutic Applications","volume":"5","author":"Zakrewsky","year":"2016","journal-title":"Advanced Healthcare Materials"},{"key":"10.1016\/j.xphs.2026.104534_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2025.128840","article-title":"Topical delivery of cisplatin via ionic liquid-based gel\u202f: A localized strategy for triple-negative breast cancer treatment","volume":"439","author":"Katari","year":"2025","journal-title":"J. Mol. Liq"},{"issue":"19","key":"10.1016\/j.xphs.2026.104534_bib0028","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1021\/jp200042f","article-title":"Ionic Liquids\u202f: Predictions of Physicochemical Properties with Experimental and \/or DFT-Calculated LFER Parameters To Understand Molecular Interactions in Solution","volume":"115","author":"Cho","year":"2011","journal-title":"The Journal of Physical Chemistry B"},{"key":"10.1016\/j.xphs.2026.104534_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2022.100110","article-title":"Current Research in Pharmacology and Drug Discovery Evaluation of synergism in drug combinations and reference models for future orientations in oncology","volume":"3","author":"Duarte","year":"2022","journal-title":"Curr. Res. Pharmacol. Drug Discov"},{"issue":"9","key":"10.1016\/j.xphs.2026.104534_bib0030","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1039\/C4MD00161C","article-title":"Imidazolium-derived ionic salts induce inhibition of cancerous cell growth through apoptosis \u2020","volume":"5","author":"Malhotra","year":"2014","journal-title":"MedChemComm"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2026.104534_bib0031","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijpharm.2016.12.026","article-title":"Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5","volume":"517","author":"Makled","year":"2017","journal-title":"Int. J. Pharm"},{"key":"10.1016\/j.xphs.2026.104534_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125310","article-title":"Excipient-free inhalable combination shell-core microparticles with clofazimine as shell for extended pulmonary retention of isoniazid in core","volume":"672","author":"Reddy","year":"2025","journal-title":"Int. J. Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2026.104534_bib0033","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/jbm.a.37485","article-title":"Choline and geranic acid ( CAGE ) ionic liquids inhibit both elastase activity and growth of oral bacteria","volume":"111","author":"Laird","year":"2023","journal-title":"Journal of Biomedical Materials Research"},{"key":"10.1016\/j.xphs.2026.104534_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.114934","article-title":"Intra- and inter-molecular interactions in choline-based ionic liquids studied by 1D and 2D NMR","volume":"322","author":"Veroutis","year":"2021","journal-title":"Journal of Molecular Liquids"},{"key":"10.1016\/j.xphs.2026.104534_bib0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2018.07.029","article-title":"Transdermal insulin delivery using choline-based ionic liquids ( CAGE )","volume":"286","author":"Tanner","year":"2018","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.xphs.2026.104534_bib0036","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1021\/acsbiomaterials.0c01324","article-title":"Structural Evaluation of the Choline and Geranic Acid \/Water Complex by SAXS and NMR Analyses","volume":"7","author":"Takeda","year":"2021","journal-title":"ACS Biomaterials Science & Engineering,"},{"key":"10.1016\/j.xphs.2026.104534_bib0037","unstructured":"Joshi, Nitin, et al., \"Ionic liquid compositions for skin diseases and condition\", United States patent application US 18\/030, 177. 2023, \u201cUS20230372273A1.pdf.\u201d"},{"issue":"2","key":"10.1016\/j.xphs.2026.104534_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/btm2.10191","article-title":"Clinical translation of choline and geranic acid deep eutectic solvent","volume":"6","author":"Ko","year":"2021","journal-title":"Bioengineering & Translational Medicine"},{"key":"10.1016\/j.xphs.2026.104534_bib0039","article-title":"Enhancement in the therapeutic potential of lapatinib ditosylate against breast cancer by the use of \u03b2 -cyclodextrin based ternary nanosponge system","volume":"642","author":"Tanaji","year":"2023","journal-title":"Int. J. Pharm"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2026.104534_bib0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijpharm.2018.09.062","article-title":"Preparation of lapatinib ditosylate solid dispersions using solvent rotary evaporation and hot melt extrusion for solubility and dissolution enhancement","volume":"552","author":"Hu","year":"2018","journal-title":"Int. J. Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2026.104534_bib0041","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1021\/acs.molpharmaceut.4c00283","article-title":"A Lipophilic Salt Form to Enhance the Lipid Solubility and Certain Biopharmaceutical Properties of Lapatinib","volume":"21","author":"Singh","year":"2024","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104534_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2021.129721","article-title":"Coconut oil-based resveratrol nanoemulsion\u202f: Optimization using response surface methodology, stability assessment and pharmacokinetic evaluation","volume":"357","author":"Kotta","year":"2021","journal-title":"Food Chem"},{"issue":"1","key":"10.1016\/j.xphs.2026.104534_bib0043","article-title":"In vivo mechanisms of resveratrol liposomes in targeting the TLR4 \/NLRP3 pathway in lung cancer","volume":"15","author":"Chen","year":"2025","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/j.xphs.2026.104534_bib0044","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3390\/pharmaceutics15041179","article-title":"Recent Advances in Biocompatible Ionic Liquids in Drug Formulation and Delivery","volume":"15","author":"Moshikur","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104534_bib0045","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jconrel.2020.03.018","article-title":"Oral delivery of sorafenib through spontaneous formation of ionic liquid nanocomplexes","volume":"322","author":"Shi","year":"2020","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.xphs.2026.104534_bib0046","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/pharmaceutics14040779","article-title":"Transdermal Permeation Assays of Curcumin Aided by CAGE-IL\u202f: In Vivo Control of Psoriasis","volume":"14","author":"Boscariol","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104534_bib0047","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijpharm.2013.08.010","article-title":"Evaluation of solubility and partition properties of ampicillin-based ionic liquids","volume":"456","author":"Florindo","year":"2013","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/j.xphs.2026.104534_bib0048","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1471-2407-10-188","article-title":"Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model","volume":"10","author":"Diaz","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xphs.2026.104534_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphys.2021.111192","article-title":"Degradation of lipid based drug delivery formulations during nebulization","volume":"547","author":"Klein","year":"2021","journal-title":"Chem. Phys"},{"issue":"21","key":"10.1016\/j.xphs.2026.104534_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.202502624R","article-title":"Advances in Inhaled Nanoparticle Drug Delivery for Pulmonary Disease Management","volume":"39","author":"Fan","year":"2025","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.xphs.2026.104534_bib0051","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-3659(02)00370-X","article-title":"N ebulization of biodegradable nanoparticles\u202f: impact of nebulizer technology and nanoparticle characteristics on aerosol features","volume":"86","author":"Ann","year":"2003","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.xphs.2026.104534_bib0052","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1039\/D4NA01034E","article-title":"Nanoscale Advances PAPER RNA lipid nanoparticles stabilized during nebulization through excipient selection \u2020","volume":"7","author":"Slaughter","year":"2025","journal-title":"Nanoscale Adv"},{"issue":"6","key":"10.1016\/j.xphs.2026.104534_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1010143","article-title":"Pulmonary drug delivery and retention: a computational study to identify plausible parameters based on a coupled airway-mucus flow model","volume":"18","author":"Chakravarty","year":"2022","journal-title":"PLoS Computational Biology"},{"issue":"5","key":"10.1016\/j.xphs.2026.104534_bib0054","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.3390\/ma16051975","article-title":"Impact of Natural-Based Viscosity Modifiers of Inhalation Drugs on the Dynamic Surface Properties of the Pulmonary Surfactant","volume":"16","author":"Dobrowolska","year":"2023","journal-title":"Materials"},{"key":"10.1016\/j.xphs.2026.104534_bib0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpharm.2007.02.035","article-title":"The influence of fluid physicochemical properties on vibrating-mesh nebulization","volume":"339","author":"Ghazanfari","year":"2007","journal-title":"International Journal of Pharmaceutics,"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:30:05Z","timestamp":1793140205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0022354926003849"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104534","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CAGE ionic liquid\u2013mediated co-solubilization of lapatinib and resveratrol enhances cytotoxicity in lung cancer cells with uniform aerosolization for pulmonary delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104534"}}